Matthew Boron
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 2
- Colorectal Cancer Treatments and Studies 1
- Cancer Immunotherapy and Biomarkers 1
- COVID-19 and healthcare impacts 1
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Don Vena (1 shared paper)Larry Rubinstein (1 shared paper)James A. Zwiebel (1 shared paper)Margaret Mooney (3 shared papers)Louise B. Grochow (1 shared paper)C. Carl Jaffe (1 shared paper)Helen X. Chen (1 shared paper)Richard Kaplan (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United States
In The Last Decade
Matthew Boron
5 papers receiving 312 citations
Peers
Comparison fields: 5 of 49
- Hepatology 57
- Oncology 141
- Public Health, Environmental and Occupational Health 82
- Genetics 25
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by Matthew Boron
This map shows the geographic impact of Matthew Boron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Boron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Boron more than expected).
Fields of papers citing papers by Matthew Boron
This network shows the impact of papers produced by Matthew Boron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Boron. The network helps show where Matthew Boron may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Boron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 161 | |
| 2 | 2010 | 118 | |
| 3 | 2004 | 51 | |
| 4 | 2005 | 2 | |
| 5 | Expanded access trial of tocilizumab in COVID19+hospitalized cancer patients | 2020 | 1 |
| 6 | 2021 | 0 |
About Matthew Boron
Matthew Boron is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Infectious Diseases, Genetics and Dermatology, having authored 6 papers that have together received 333 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (2 papers), Colorectal Cancer Treatments and Studies (1 paper), COVID-19 Clinical Research Studies (1 paper), Poisoning and overdose treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Hepatology (57 citations), Oncology (141 citations), Public Health, Environmental and Occupational Health (82 citations), Genetics (25 citations) and Pulmonary and Respiratory Medicine (63 citations). Matthew Boron has collaborated with scholars based in United States. Frequent co-authors include Don Vena, Larry Rubinstein, James A. Zwiebel, Margaret Mooney, Louise B. Grochow, C. Carl Jaffe, Helen X. Chen, Richard Kaplan, Aiman Shalabi and Percy Ivy. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.